Breast or ovarian cancer endometrial cancer vulvar neoplasms. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy9

Breast Cell Line, Tumor Tumor Cells, Cultured Endometrium Neoplastic Stem Cells Epithelial Cells Ovary MCF-7 Cells Lymph Nodes

Organisms2

Mice, Nude Mice, SCID

Diseases68

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Cystadenocarcinoma, Serous Neoplasm Invasiveness Neoplasms Carcinoma Breast Neoplasms Neoplasm Metastasis Pancreatic Neoplasms Breast Diseases Carcinoma, Ductal, Breast Lung Neoplasms Genetic Predisposition to Disease Adenocarcinoma, Clear Cell Prostatic Neoplasms Neoplasm Recurrence, Local Colonic Neoplasms Adenocarcinoma Uterine Neoplasms Adenocarcinoma, Mucinous Stomach Neoplasms Endometrial Hyperplasia Genital Neoplasms, Female Disease Progression Neoplasms, Multiple Primary Neoplasms, Second Primary Uterine Cervical Neoplasms Breast Neoplasms, Male Neoplasms, Cystic, Mucinous, and Serous Peritoneal Neoplasms Colorectal Neoplasms Cell Transformation, Neoplastic Neoplasms, Hormone-Dependent Cystadenocarcinoma, Papillary Colorectal Neoplasms, Hereditary Nonpolyposis Skin Neoplasms Urinary Bladder Neoplasms Carcinoma, Squamous Cell Adenocarcinoma, Papillary Cystadenocarcinoma Liver Neoplasms Bone Neoplasms Neovascularization, Pathologic Precancerous Conditions Ascites Neoplasms, Radiation-Induced Carcinoma, Non-Small-Cell Lung Carcinoma, Intraductal, Noninfiltrating Thyroid Neoplasms Rectal Neoplasms Kidney Neoplasms Mammary Neoplasms, Experimental Gastrointestinal Neoplasms Carcinoma, Lobular Carcinoma, Papillary Fibrocystic Breast Disease Cystadenocarcinoma, Mucinous Neoplasms, Experimental Mouth Neoplasms Esophageal Neoplasms Neoplastic Syndromes, Hereditary Lymphatic Metastasis Head and Neck Neoplasms Carcinoma in Situ Mixed Tumor, Mullerian

Chemicals and Drugs49

Tumor Markers, Biological CA-125 Antigen Neoplasm Proteins Antineoplastic Agents Receptors, Estrogen Tamoxifen Receptors, Progesterone DNA, Neoplasm Receptor, erbB-2 Estrogens RNA, Messenger Antineoplastic Agents, Hormonal BRCA2 Protein Cisplatin Paclitaxel BRCA1 Protein Antigens, Neoplasm RNA, Small Interfering Cancer Vaccines Antineoplastic Agents, Phytogenic Tumor Suppressor Protein p53 Estrogen Receptor alpha Progestins Estrogen Antagonists Contraceptives, Oral RNA, Neoplasm Tumor Suppressor Proteins Epididymal Secretory Proteins Antibodies, Monoclonal Carboplatin DNA-Binding Proteins Nuclear Proteins PTEN Phosphohydrolase MicroRNAs Proto-Oncogene Proteins c-akt Transcription Factors Proto-Oncogene Proteins Receptor, Epidermal Growth Factor Selective Estrogen Receptor Modulators Fluorouracil Anticarcinogenic Agents Taxoids Estradiol Ki-67 Antigen Antigens, Tumor-Associated, Carbohydrate Antibodies, Monoclonal, Humanized Prostate-Specific Antigen Aromatase Inhibitors Adaptor Proteins, Signal Transducing

Analytical, Diagnostic and Therapeutic Techniques and Equipment68

Neoplasm Staging Early Detection of Cancer Prognosis Risk Factors Survival Analysis Risk Immunohistochemistry Case-Control Studies Survival Rate Reverse Transcriptase Polymerase Chain Reaction Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Prospective Studies Follow-Up Studies Odds Ratio Disease-Free Survival Gene Expression Profiling Xenograft Model Antitumor Assays Hysterectomy Risk Assessment Mammography Blotting, Western Registries Incidence Neoplasm Transplantation Sensitivity and Specificity Neoplasm Grading Chemotherapy, Adjuvant Cohort Studies Treatment Outcome Kaplan-Meier Estimate Oligonucleotide Array Sequence Analysis Multivariate Analysis Transplantation, Heterologous Tissue Array Analysis Logistic Models Genetic Testing Salpingectomy Polymerase Chain Reaction Estrogen Replacement Therapy SEER Program Immunoenzyme Techniques Drug Screening Assays, Antitumor Questionnaires Confidence Intervals Combined Modality Therapy Tumor Burden Predictive Value of Tests Mastectomy Transfection Molecular Targeted Therapy Reproducibility of Results Lymph Node Excision DNA Mutational Analysis Clinical Trials as Topic Gene Knockdown Techniques Mammary Neoplasms, Experimental Breast Self-Examination Radiotherapy, Adjuvant Drug Administration Schedule Body Mass Index Hormone Replacement Therapy Biopsy Neoplasms, Experimental Radiotherapy Reproductive History Models, Biological Biopsy, Needle

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes51

Gene Expression Regulation, Neoplastic Genes, BRCA1 Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Postmenopause Cell Proliferation Mutation Odds Ratio Genes, BRCA2 Germ-Line Mutation Apoptosis DNA Methylation Sensitivity and Specificity Genotype Breast Feeding Menopause Cell Growth Processes Signal Transduction Polymorphism, Genetic Cell Division Premenopause Down-Regulation Cell Movement Gene Silencing Genes, Tumor Suppressor Cell Cycle Cell Survival Dose-Response Relationship, Drug Promoter Regions, Genetic Time Factors Parity Transfection Up-Regulation RNA Interference Gene Expression Base Sequence Genes, Neoplasm Alleles Heterozygote Genes, p53 Diet Body Mass Index Genes, erbB-2 Phenotype Loss of Heterozygosity Microsatellite Repeats Gene Amplification Phosphorylation Drug Synergism Epithelial-Mesenchymal Transition

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Incidence SEER Program Questionnaires Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care31

Risk Factors Survival Analysis Risk Case-Control Studies Survival Rate Retrospective Studies Prospective Studies Follow-Up Studies Odds Ratio Disease-Free Survival Risk Assessment Registries Age Factors Incidence Sensitivity and Specificity Cohort Studies Treatment Outcome Kaplan-Meier Estimate Multivariate Analysis Logistic Models Genetic Testing SEER Program Questionnaires Confidence Intervals Predictive Value of Tests Parity Reproducibility of Results National Cancer Institute (U.S.)Clinical Trials as Topic Body Mass Index Reproductive History

Geographicals4

United States China Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Vulvar Neoplasms Endometrial Neoplasms Ovarian Neoplasms Breast Carcinoma, Endometrioid Neoplasms, Glandular and Epithelial Cell Line, Tumor Cystadenocarcinoma, Serous Neoplasm Invasiveness Gene Expression Regulation, Neoplastic Neoplasm Staging Early Detection of Cancer Tumor Markers, Biological Prognosis Neoplasms Carcinoma Breast Neoplasms CA-125 Antigen Neoplasm Proteins Neoplasm Metastasis Pancreatic Neoplasms Genes, BRCA1 Risk Factors Breast Diseases Carcinoma, Ductal, Breast Mice, Nude Antineoplastic Agents Receptors, Estrogen Lung Neoplasms Genetic Predisposition to Disease Drug Resistance, Neoplasm Tamoxifen Adenocarcinoma, Clear Cell Survival Analysis Risk Prostatic Neoplasms Immunohistochemistry Case-Control Studies Receptors, Progesterone Survival Rate Neoplasm Recurrence, Local DNA, Neoplasm Colonic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Adenocarcinoma Antineoplastic Combined Chemotherapy Protocols Uterine Neoplasms Receptor, erbB-2 Retrospective Studies Postmenopause Adenocarcinoma, Mucinous Stomach Neoplasms Endometrial Hyperplasia Estrogens Prospective Studies Tumor Cells, Cultured Cell Proliferation Follow-Up Studies Mutation Odds Ratio RNA, Messenger Antineoplastic Agents, Hormonal Disease-Free Survival Gene Expression Profiling Genes, BRCA2 Genital Neoplasms, Female Xenograft Model Antitumor Assays Germ-Line Mutation Hysterectomy Disease Progression BRCA2 Protein Neoplasms, Multiple Primary Risk Assessment Cisplatin Paclitaxel Neoplasms, Second Primary BRCA1 Protein Mammography Blotting, Western Registries Uterine Cervical Neoplasms Breast Neoplasms, Male Age Factors Incidence Apoptosis DNA Methylation Neoplasm Transplantation Neoplasms, Cystic, Mucinous, and Serous United States Peritoneal Neoplasms Endometrium Sensitivity and Specificity Colorectal Neoplasms Antigens, Neoplasm Neoplasm Grading RNA, Small Interfering Genotype Chemotherapy, Adjuvant Cancer Vaccines Cohort Studies

No FAQ available that match "breast or ovarian cancer endometrial cancer vulvar neoplasms"